Accepted for/Published in: JMIR Pediatrics and Parenting
Date Submitted: Oct 31, 2025
Date Accepted: Jun 16, 2026
A Pilot Lifestyle Intervention to Support Adolescent Metabolic and Bariatric Surgery Completers: Feasibility and Exploratory Outcomes
ABSTRACT
Background:
Metabolic and bariatric surgery (MBS) is a safe and effective treatment for adolescents with severe obesity, yet no standardized lifestyle interventions exist to support sustained behavior change post-MBS.
Objective:
This pilot study assessed the feasibility and acceptability of TeenLyft, an online lifestyle support program for adolescents undergoing MBS, and explored preliminary clinical and safety outcomes to inform the design of a future randomized trial.
Methods:
Adolescents aged 12–18 years were recruited from a tertiary care MBS center and enrolled in TeenLyft. The study was not powered or designed as a randomized controlled trial but rather as a pilot to guide future RCT development. Feasibility domains included recruitment, retention, data completeness, intervention fidelity, and engagement, with predefined progression criteria of ≥80% enrollment, ≥70% retention, ≥75% data completeness, and ≥90% fidelity. Exploratory clinical and safety measures (weight, BMI, and cardiometabolic markers) were collected descriptively to confirm that participation was not associated with harm.
Results:
Twenty-nine adolescents (mean age 15.9 years; 75.9% female; 44.8% Hispanic; mean BMI 47.8 kg/m²) were enrolled, representing 145% of the recruitment target (n=20), with 72% retention at six months. All feasibility progression criteria were met. Descriptive trends showed expected post-MBS reductions in weight and BMI and improvements in blood pressure and HbA1c, with no adverse cardiometabolic effects observed.
Conclusions:
TeenLyft demonstrated high feasibility, acceptability, and safety as an adjunct to adolescent MBS care. Findings support progression to a fully powered randomized trial to evaluate long-term effectiveness and sustainability. Clinical Trial: ClinicalTrials.gov, NCT05393570; Registered on May 16, 2022.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.